Cytori Therapeutics Inc. (CYTX)
NASDAQ: Health Care
$2.25
0.07 | 3.21%
0.07 | 3.21%
Today's Range:
2.13 -
2.28
CYTX Avg. Daily Volume:
440,300
05/29/12 - 1:59 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 2.18 |
| 52 Week High | 5.80 |
| 52 Week Low | 1.90 |
| Avg. Daily Vol. (Mil) | 0.44 |
| Beta (3 year) | 2.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 127.94 |
| Shares Out (Mil) | 58.69 |
| Float (Mil) | 56.84 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.30 |
| Current Ratio | 3.70 |
| LT Debt/ Equity | 2.88 |
| Total Debt / Equity | 3.59 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 18.62 |
| Price/Book | 18.68 |
| Price/Cash Flow | -4.60 |
| Per Share Data | |
| Earnings | -0.54 |
| Sales | 0.12 |
| Book Value | 0.12 |
| Cash Flow | -0.48 |
| Business Summary | |
|---|---|
| Cytori Therapeutics, Inc. develops, manufactures and sells medical products to enable the practice of regenerative medicine. | |
| General Information | |
| 3020 Callan Road
San Diego, CA 92121 |
|
| www.cytoritx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 128 | |
| CEO: Christopher J. Calhoun | |
| Short Interest | |
| Current Month (Mil) | 9.37 |
| Previous Month (Mil) | 9.36 |
| Short Interest Ratio (Days) | 30.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -60.50 |
| Return on Investments | -111.00 |
| Profitability | |
| Gross Margin | 67.10 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,536.57 | 1,325.68 | 2,860.50 | 17.19 |
Oil *
106.65
|
|
UP
81.74 |
UP
7.86 |
UP
22.97 |
DOWN
0.26 |
10 Yr
1.72%
SPDR Gold
150.66
|
|
+0.66%
|
+0.60%
|
+0.81%
|
-1.49%
|
Data delayed 20 minutes |
Connect with TheStreet